The group's principal activity is to provide pharmaceutical products. The group's services include broad therapeutic expertise, epidemiology and risk management, outcomes research, systematic review and meta analysis, investigator services, patient programs, life science training services, electronic data capture, regulatory affairs, data management, biostatics programming and medical writing. The group operates from the United States.
